Clinical Trials Browser

Phase 3 × Triple Negative Breast Neoplasms × toripalimab × Clear all

NCT07111832 2025-12-18

A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer

Phase 3 Recruiting

Triple Negative Breast Neoplasms